TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/24/2024
Back to search
Official data from USPTO
SENSI PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SENSI PHARMA
ST13
US500000088831545Class
5, 40, 44
Filing
88831545
Registration
6784395
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
06/24/2024
Trademark type
Word
Nice classes
5, 40, 44
Filing date
03/12/2020
Registration date
07/12/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/12/2022
Last transaction
06/24/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
Amsterdam, NL
Examiner
BAGLINI, KAREN
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Dronkers IP B.V.
Representatives
Daniel P. Mullarkey Polsinelli PC
Technical classification
Nice Classes
Class 5Class 40Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
sanitary preparations for medical purposes; dietetic supplementsdietary and nutritional supplements; dietetic preparations adapted for medical purposes; infant formula; dietary supplements; protein supplements; protein powder for use as a dietary supplement; protein for use as a dietary supplement in powdered mixtures and prepared drinks; protein supplements formed and packaged as bars; powdered nutritional supplement drink mix; mineral dietary and nutritional supplements for human use; health food supplements for persons with special dietary requirements; dietetic foods and beverages adapted for medical use; balms for medical and pharmaceutical purposes; water balm for medical purposes; plant and herbal extracts for medical and pharmaceutical purposes; suppositories being pharmaceutical preparations for the prevention and treatment of infections; medicinal oils; all of the foregoing containing ingredients solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD
Class 40
Processing of industrial hemp plants to form raw materials; Stripping of industrial hemp wood; Processing of flax plants to form raw materials; Consultancy and information regarding the aforesaid services; The aforesaid consultancy and information services also provided via electronic networkssuch as the Internetall of the foregoing services relating only to hemp solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD
Class 44
Pest control services for agricultureaquaculturehorticulture and forestry services; Cultivation of flax plants; Consultancy and information regarding the aforesaid services; The aforesaid consultancy and information services also provided via electronic networksincluding the Internet
Publications
History of USPTO decisions and trademark events.
35 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/24/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/24/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/24/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/12/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
07/12/2022
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
06/02/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/02/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
04/25/2022
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
04/25/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/01/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/04/2022
PUBO
PUBLISHED FOR OPPOSITION
01/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/15/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/01/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
12/01/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/01/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
12/01/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/01/2021
DOCK
ASSIGNED TO EXAMINER
10/13/2021
DOCK
ASSIGNED TO EXAMINER
06/23/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/15/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/15/2021
ALIE
ASSIGNED TO LIE
06/15/2021
NREV
NOTICE OF REVIVAL - E-MAILED
03/26/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/25/2021
PETG
PETITION TO REVIVE-GRANTED
03/25/2021
PROA
TEAS PETITION TO REVIVE RECEIVED
03/25/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/23/2020
GNRT
NON-FINAL ACTION E-MAILED
09/23/2020
CNRT
NON-FINAL ACTION WRITTEN
09/23/2020
DOCK
ASSIGNED TO EXAMINER
09/23/2020
DOCK
ASSIGNED TO EXAMINER
06/04/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/18/2020
NWAP
NEW APPLICATION ENTERED
03/16/2020
Continuous trademark protection
Get notified about every new filing that threatens SENSI PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.